These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36600471)

  • 1. Effect of nutritional status before radiotherapy on radiation-induced acute toxicities in patients with nasopharyngeal carcinoma.
    Song X; Su L; Lin Q; Liu S; Zhang W; Hong J
    Head Neck; 2023 Mar; 45(3):620-628. PubMed ID: 36600471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trismus, xerostomia and nutrition status in nasopharyngeal carcinoma survivors treated with radiation.
    Chen YJ; Chen SC; Wang CP; Fang YY; Lee YH; Lou PJ; Ko JY; Chiang CC; Lai YH
    Eur J Cancer Care (Engl); 2016 May; 25(3):440-8. PubMed ID: 25495287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of protective effects on salivary and swallowing structures and improvement of late xerostomia and dysphagia by level IIb optimisation in clinical target volume of nasopharyngeal carcinoma.
    Zhou J; Wang L; Qiu T; Gao H; Wang L; Huang S; He X; Wu L
    BMC Cancer; 2024 May; 24(1):648. PubMed ID: 38802747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of nutritional impairment on treatment-related toxicity and survival in patients with nasopharyngeal carcinoma taking normal nutrition before radiotherapy.
    Su L; Lin Q; Li R; Hua Y; Zhang H; Song X; Ye J; Zhang W; Hong J
    Head Neck; 2020 Dec; 42(12):3580-3589. PubMed ID: 32851765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nomogram for predicting late radiation-induced xerostomia among locoregionally advanced nasopharyngeal carcinoma in intensity modulated radiation therapy era.
    Yang K; Xie W; Zhang X; Wang Y; Shou A; Wang Q; Tian J; Yang J; Li G
    Aging (Albany NY); 2021 Jul; 13(14):18645-18657. PubMed ID: 34282056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definitive intensity-modulated radiation therapy for nasopharyngeal carcinoma: long-term outcome of a multicenter prospective study.
    Wang R; Wu F; Lu H; Wei B; Feng G; Li G; Liu M; Yan H; Zhu J; Zhang Y; Hu K
    J Cancer Res Clin Oncol; 2013 Jan; 139(1):139-45. PubMed ID: 22986812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome and late toxicities of simultaneous integrated boost-intensity modulated radiotherapy in pediatric and adolescent nasopharyngeal carcinoma.
    Tao CJ; Liu X; Tang LL; Mao YP; Chen L; Li WF; Yu XL; Liu LZ; Zhang R; Lin AH; Ma J; Sun Y
    Chin J Cancer; 2013 Oct; 32(10):525-32. PubMed ID: 24016394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiety and depression status prior to radiotherapy in patients with nasopharyngeal carcinoma and its effect on acute radiation toxicities.
    Li R; Su L; Hua Y; Ye JR; Song XR; Tian J; Song JH; Hong JS
    Eur J Cancer Care (Engl); 2021 Nov; 30(6):e13487. PubMed ID: 34219307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
    Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
    Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Survivals, Toxicities and the Role of Chemotherapy in Early-Stage Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiation Therapy: A Retrospective Study with 15-Year Follow-up.
    Wang L; Miao J; Huang H; Chen B; Xiao X; Zhu M; Liang Y; Xiao W; Huang S; Peng Y; Deng X; Lv X; Xia W; Xiang Y; Guo X; Han F; Zhao C
    Cancer Res Treat; 2022 Jan; 54(1):118-129. PubMed ID: 34098625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
    Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
    Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Intensity-Modulated Radiation Therapy on the Life Quality of Patients with Nasopharyngeal Carcinoma.
    Chen J; Liu P; Wang Q; Wu L; Zhang X
    Cell Biochem Biophys; 2015 Dec; 73(3):731-6. PubMed ID: 27259317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy in locally advanced nasopharyngeal carcinoma: Comparative study at SKIMS Tertiary Care Institute.
    Fatima K; Andleeb A; Sofi MA; Rasool MT; Fir A; Nasreen S; Dar NA
    J Cancer Res Ther; 2022; 18(1):133-139. PubMed ID: 35381774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute toxicity in nasopharyngeal carcinoma patients treated with IMRT/VMAT.
    Ozdemir S; Akin M; Coban Y; Yildirim C; Uzel O
    Asian Pac J Cancer Prev; 2015; 16(5):1897-900. PubMed ID: 25773841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma.
    Lertbutsayanukul C; Prayongrat A; Kannarunimit D; Chakkabat C; Netsawang B; Kitpanit S
    Strahlenther Onkol; 2018 May; 194(5):375-385. PubMed ID: 29302704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic nomogram of xerostomia for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy.
    Pan XB; Liu Y; Li L; Qu S; Chen L; Liang SX; Chen KH; Liang ZG; Zhu XD
    Aging (Albany NY); 2020 Jan; 12(2):1857-1866. PubMed ID: 32005029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between XRCC1 single-nucleotide polymorphism and acute radiation reaction in patients with nasopharyngeal carcinoma: A cohort study.
    Chen H; Wu M; Li G; Hua L; Chen S; Huang H
    Medicine (Baltimore); 2017 Nov; 96(44):e8202. PubMed ID: 29095251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neck level Ib-sparing versus level Ib-irradiation in intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma with high-risk factors: A propensity score-matched cohort study.
    Wang G; Huang C; Yang K; Guo R; Qiu Y; Li W; Mao Y; Tang L; Ma J
    Radiother Oncol; 2022 Dec; 177():205-213. PubMed ID: 36375564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors for improvement of xerostomia in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy.
    Pan XB; Liu Y; Huang ST; Chen KH; Jiang YM; Zhu XD
    Medicine (Baltimore); 2019 Sep; 98(36):e17030. PubMed ID: 31490391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLIM Criteria-Defined Malnutrition Informs on Survival of Nasopharyngeal Carcinoma Patients Undergoing Radiotherapy.
    Wan M; Zhang L; Chen C; Zhao D; Zheng B; Xiao S; Liu W; Xu X; Wang Y; Zhuang B; Zhang T; Jin S; Wang W; Lu Q; Sun Y
    Nutr Cancer; 2022; 74(8):2920-2929. PubMed ID: 35225113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.